Astera Labs (NASDAQ:ALAB) Posts Quarterly Earnings Results, Misses Expectations By $0.16 EPS

Astera Labs (NASDAQ:ALAB) posted its quarterly earnings results on Monday. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.16), Zacks reports. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. Astera Labs updated its Q1 2025 guidance to 0.280-0.290 EPS.

Astera Labs Stock Performance

Shares of ALAB opened at $103.29 on Tuesday. The firm’s fifty day simple moving average is $122.39 and its 200-day simple moving average is $82.15. Astera Labs has a twelve month low of $36.22 and a twelve month high of $147.39.

Insider Buying and Selling

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 197,297 shares of the firm’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the transaction, the director now directly owns 6,148 shares of the company’s stock, valued at approximately $556,455.48. This trade represents a 96.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Jitendra Mohan sold 171,064 shares of the firm’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $103.53, for a total transaction of $17,710,255.92. Following the transaction, the chief executive officer now directly owns 628,895 shares in the company, valued at $65,109,499.35. The trade was a 21.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 846,452 shares of company stock worth $86,427,256 in the last ninety days.

Analysts Set New Price Targets

Several analysts have recently weighed in on ALAB shares. Morgan Stanley dropped their price target on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 28th. Roth Mkm increased their price objective on shares of Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. JPMorgan Chase & Co. increased their price objective on shares of Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 5th. Citigroup started coverage on shares of Astera Labs in a research report on Monday, November 18th. They set a “buy” rating and a $120.00 price objective for the company. Finally, Craig Hallum increased their price objective on shares of Astera Labs from $75.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $107.42.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.